CYTK earnings call for the period ending June 30, 2019.
News & Analysis: Cytokinetics
CYTK earnings call for the period ending March 31, 2019.
The clinical-stage biotech's long-running partnership with Amgen took another big step forward.
CYTK earnings call for the period ending December 31 2018.
The biotech will join the S&P SmallCap 600 index.
What the biotech didn't say might have caused its downfall.
Cytokinetics Inc. shares jumped by over 10% earlier in the day after reporting financial results for 2015.
Shares of the clinical-stage biopharma Cytokinetics roared higher today. Here's why.
Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.
Find out which biotech posted the best, and worst, clinical results last week.